Fritz Blatter

10 Patents

• US125456862026

  Polymorphic Forms of (s)-n-(3-bromo-2-fluorophenyl)-7-((4-methylpiperazin-1-yl)methyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolin-4-amine as EGFR Inhibitors

  KATMAI PHARMACEUTICALS, Inc.

  0 cites
• US122864002025

  Isofagomine Salts, Methods of Use and Formulations

  TAKEDA PHARMACEUTICAL COMPANY LIMITED

  0 cites
• US122214452025

  Crystalline Salts of 5-methyl-(6s)-tetrahydrofolic Acid and Amino Ethyl Esters

  MERCK PATENT GmbH

  0 cites
• US122214462025

  Crystalline Salt of 5-methyl-(6s)-tetrahydrofolic Acid and L-isoleucine Ethyl Ester

  0 cites
• US121163442024

  Crystalline Forms of a Pharmaceutical Compound

  Azafaros B.V.

  0 cites
• US120487002024

  Crystalline Monosodium Salt of 5-methyl-(6s)-tetrahydrofolic Acid

  MERCK PATENT GmbH

  0 cites
• US119924912024

  Crystalline Salts of 5-methyl-(6s)-tetrahydrofolic Acid and L-valine Ethyl Ester

  MERCK PATENT GmbH

  0 cites
• US119256442024

  Crystalline Salts of 5-methyl-(6s)-tetrahydrofolic Acid and L-leucine Ethyl Ester

  MERCK PATENT GmbH

  0 cites
• US118207772023

  Crystal Forms of (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide

  Acerta Pharma B.V.

  0 cites
• US116334002023

  Crystalline Salt Comprising 5-methyl-(6s)-tetrahydrofolic Acid and 4-(2-hydroxyethyl)-morpholine

  MERCK PATENT GmbH

  0 cites